NanoMedical Systems, Inc.
Austin
About NanoMedical Systems, Inc.
NanoMedical Systems develops novel drug-delivery devices based on its proprietary nStrada™ nanofluidics platform for sustained release of chronic therapies. These devices can be loaded with a variety of drugs including small molecules, peptides, and proteins for subcutaneous implantation. The nStrada™ devices rely on diffusion (passive or controlled) to achieve steady-state drug concentrations within a few days and then maintain constant release for the duration of the implant. This performance represents a significant improvement over polymer-based implants and depots which suffer from an initial burst release and multiple weeks to achieve steady-state concentrations.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.2M
- Last round: Grant (Aug 2018)
- Website: nanomedsys.com
- Phone: 15126144437
Industries & Categories
Biotechnology, Medical, Nanotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/nanomedical-systems-inc-17865 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.